86.90.0
Прочая деятельность в области здравоохранения
270
Учреждение
03873
Министерство здравоохранения Республики Узбекистан
1714367
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
Information found about participation in government procurement as a supplier or customer
Supplier
0
Customer
68
Коротко о компании
YANGI NAMANGAN TUMANI SANITARIYA-EPIDEMIOLOGIK OSOYISHTALIK VA JAMOAT SALOMATLIGI BO`LIMI has been operating since 2021 in the "Прочая деятельность в области здравоохранения" industry. The director is Kosimov Davlat Tojidinovich. The company belongs to the "Small business" category. Its primary activity is "Прочая деятельность в области здравоохранения". The company has 1 founders, one of whom owns a 100% stake. The company is not engaged in licensed activities.. The company has no registered property., is included in 0, and has 312 similar companies, indicating a developed competitive market.
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
25
0
25
0
No data on licenses
No data on real estate
No data on trademarks
Коротко о компании
YANGI NAMANGAN TUMANI SANITARIYA-EPIDEMIOLOGIK OSOYISHTALIK VA JAMOAT SALOMATLIGI BO`LIMI has been operating since 2021 in the "Прочая деятельность в области здравоохранения" industry. The director is Kosimov Davlat Tojidinovich. The company belongs to the "Small business" category. Its primary activity is "Прочая деятельность в области здравоохранения". The company has 1 founders, one of whom owns a 100% stake. The company is not engaged in licensed activities.. The company has no registered property., is included in 0, and has 312 similar companies, indicating a developed competitive market.